Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'.

@article{Ylamos2017ReplyT,
  title={Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'.},
  author={Oriol Y{\'e}lamos and Allan C. Halpern and Martin A. Weinstock},
  journal={The British journal of dermatology},
  year={2017},
  volume={176 2},
  pages={
          551-552
        }
}
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS